Terms: = Colorectal cancer AND TRA
20 results:
1. [Analysis of the experience and procedural complications of trans-radial access versus trans-femoral access for hepatic arterial perfusion chemotherapy in patients with advanced hepatic malignancies:a retrospective study].
Lyu TY; Li M; He JA; Sun QF; Wang L; Qin H; Yu HP
Zhonghua Nei Ke Za Zhi; 2024 Feb; 63(2):183-191. PubMed ID: 38326045
[No Abstract] [Full Text] [Related]
2. Anti-VEGF and Anti-EGFR Antibody Therapy on T-Cell Infiltration and TCR Variation in Metastatic colorectal cancer.
Xu M; Tsunedomi R; Kiyotani K; Tomochika S; Furuya K; Nakajima M; Matsui H; Tokumitsu Y; Shindo Y; Yoshida S; Iida M; Suzuki N; Takeda S; Ioka T; Hazama S; Nagano H
Anticancer Res; 2023 Feb; 43(2):613-620. PubMed ID: 36697107
[TBL] [Abstract] [Full Text] [Related]
3. Tumor suppressor miR-193a-3p enhances efficacy of BRAF/MEK inhibitors in BRAF-mutated colorectal cancer.
Hiraide S; Takahashi M; Yoshida Y; Yamada H; Komine K; Ishioka C
Cancer Sci; 2021 Sep; 112(9):3856-3870. PubMed ID: 34288281
[TBL] [Abstract] [Full Text] [Related]
4. Laparoscopic versus open complete meso-colic excision for right-sided colon cancer. Analysis of short-term outcomes.
Erdogan O; Teke Z; Yalav O; Eray IC; Rencuzogullari A
Ann Ital Chir; 2021; 92():48-58. PubMed ID: 33650991
[TBL] [Abstract] [Full Text] [Related]
5. Colon adenocarcinoma-derived cells that express induced-pluripotent stem cell markers possess stem cell function.
Munro MJ; Peng L; Wickremesekera SK; Tan ST
PLoS One; 2020; 15(5):e0232934. PubMed ID: 32428045
[TBL] [Abstract] [Full Text] [Related]
6. A phase I study investigation of metabolism, and disposition of [
Liu Y; Liu L; Liu L; Wang T; Guo L; Wang Y; Gao Z; Shu Y
Cancer Chemother Pharmacol; 2020 May; 85(5):907-915. PubMed ID: 32266457
[TBL] [Abstract] [Full Text] [Related]
7. Preclinical development of T-cell receptor-engineered T-cell therapy targeting the 5T4 tumor antigen on renal cell carcinoma.
Xu Y; Morales AJ; Cargill MJ; Towlerton AMH; Coffey DG; Warren EH; Tykodi SS
Cancer Immunol Immunother; 2019 Dec; 68(12):1979-1993. PubMed ID: 31686124
[TBL] [Abstract] [Full Text] [Related]
8. Cellular prion protein (PrP
Provenzano L; Ryan Y; Hilton DA; Lyons-Rimmer J; Dave F; Maze EA; Adams CL; Rigby-Jones R; Ammoun S; Hanemann CO
Oncogene; 2017 Nov; 36(44):6132-6142. PubMed ID: 28692055
[TBL] [Abstract] [Full Text] [Related]
9. Human mass balance study and metabolite profiling of
van Andel L; Zhang Z; Lu S; Kansra V; Agarwal S; Hughes L; Tibben MM; Gebretensae A; Lucas L; Hillebrand MJX; Rosing H; Schellens JHM; Beijnen JH
Invest New Drugs; 2017 Dec; 35(6):751-765. PubMed ID: 28303528
[TBL] [Abstract] [Full Text] [Related]
10. New Monoclonal Antibodies to Defined Cell Surface Proteins on Human Pluripotent Stem Cells.
O'Brien CM; Chy HS; Zhou Q; Blumenfeld S; Lambshead JW; Liu X; Kie J; Capaldo BD; Chung TL; Adams TE; Phan T; Bentley JD; McKinstry WJ; Oliva K; McMurrick PJ; Wang YC; Rossello FJ; Lindeman GJ; Chen D; Jarde T; Clark AT; Abud HE; Visvader JE; Nefzger CM; Polo JM; Loring JF; Laslett AL
Stem Cells; 2017 Mar; 35(3):626-640. PubMed ID: 28009074
[TBL] [Abstract] [Full Text] [Related]
11. Clinical significance of glycoprotein nonmetastatic B and its association with HER2 in breast cancer.
Kanematsu M; Futamura M; Takata M; Gaowa S; Yamada A; Morimitsu K; Morikawa A; Mori R; Hara H; Yoshida K
Cancer Med; 2015 Sep; 4(9):1344-55. PubMed ID: 26077887
[TBL] [Abstract] [Full Text] [Related]
12. Ets1 and heat shock factor 1 regulate transcription of the transformer 2β gene in human colon cancer cells.
Kajita K; Kuwano Y; Kitamura N; Satake Y; Nishida K; Kurokawa K; Akaike Y; Honda M; Masuda K; Rokutan K
J Gastroenterol; 2013 Nov; 48(11):1222-33. PubMed ID: 23361474
[TBL] [Abstract] [Full Text] [Related]
13. Dicer 1, ribonuclease type III modulates a reprogramming effect in colorectal cancer cells.
Dewi DL; Ishii H; Haraguchi N; Nishikawa S; Kano Y; Fukusumi T; Ozaki M; Saito T; Sakai D; Satoh T; Doki Y; Mori M
Int J Mol Med; 2012 Jun; 29(6):1060-4. PubMed ID: 22446887
[TBL] [Abstract] [Full Text] [Related]
14. Hypoxia and TP53 deficiency for induced pluripotent stem cell-like properties in gastrointestinal cancer.
Hoshino H; Nagano H; Haraguchi N; Nishikawa S; Tomokuni A; Kano Y; Fukusumi T; Saito T; Ozaki M; Sakai D; Satoh T; Eguchi H; Sekimoto M; Doki Y; Mori M; Ishii H
Int J Oncol; 2012 May; 40(5):1423-30. PubMed ID: 22293932
[TBL] [Abstract] [Full Text] [Related]
15. Suitability of semi-automated tumor response assessment of liver metastases using a dedicated software package.
Kalkmann J; Ladd SC; de Greiff A; Forsting M; Stattaus J
Rofo; 2010 Jul; 182(7):581-8. PubMed ID: 20419616
[TBL] [Abstract] [Full Text] [Related]
16. Defined factors induce reprogramming of gastrointestinal cancer cells.
Miyoshi N; Ishii H; Nagai K; Hoshino H; Mimori K; Tanaka F; Nagano H; Sekimoto M; Doki Y; Mori M
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):40-5. PubMed ID: 20018687
[TBL] [Abstract] [Full Text] [Related]
17. Treatment of human colon cancer xenografts with tra-8 anti-death receptor 5 antibody alone or in combination with CPT-11.
Oliver PG; LoBuglio AF; Zinn KR; Kim H; Nan L; Zhou T; Wang W; Buchsbaum DJ
Clin Cancer Res; 2008 Apr; 14(7):2180-9. PubMed ID: 18381960
[TBL] [Abstract] [Full Text] [Related]
18. Comparing solutions to the expectancy-value muddle in the theory of planned behaviour.
O' Sullivan B; McGee H; Keegan O
Br J Health Psychol; 2008 Nov; 13(Pt 4):789-802. PubMed ID: 18215337
[TBL] [Abstract] [Full Text] [Related]
19. Human mass balance study of the novel anticancer agent ixabepilone using accelerator mass spectrometry.
Beumer JH; Garner RC; Cohen MB; Galbraith S; Duncan GF; Griffin T; Beijnen JH; Schellens JH
Invest New Drugs; 2007 Aug; 25(4):327-34. PubMed ID: 17347871
[TBL] [Abstract] [Full Text] [Related]
20. Antiinvasive effects of Tiazofurin on liver-metastatic human colon carcinoma xenografts.
Lapis KY; Bocsi J; Tóvári J; Bartha I; Timár J; Rásó E
Anticancer Res; 1996; 16(6A):3323-31. PubMed ID: 9042307
[TBL] [Abstract] [Full Text] [Related]
